治疗性血浆置换对脓毒性休克中组织因子及组织因子途径抑制剂的影响
该研究为汇总性事后生物样本库分析,纳入51例早期(休克发生<24小时)且严重(去甲肾上腺素剂量>0.4 μg/kg/min)的脓毒性休克患者,其中标准治疗组14例、标准治疗+单次治疗性血浆置换组37例。结果显示治疗性血浆置换组组织因子相对变化为-18.3%(p<0.001)、组织因子途径抑制剂为-20%(p<0.001),而标准治疗组无显著变化;两组组织因子与组织因子途径抑制剂比值均未改变。标准治疗组基线组织因子和组织因子途径抑制剂较高者24小时内乳酸升高,而治疗性血浆置换组在所有基线水平下乳酸均持续下降;多因素混合效应模型显示基线组织因子(p=0.003)和基线组织因子途径抑制剂(p=0.053)越高,治疗性血浆置换组乳酸下降幅度越大。作者认为基线组织因子和组织因子途径抑制剂水平可能作为未来临床试验预测富集策略的治疗反应预测指标。
要点
- 在早期(休克发生<24小时)且严重(去甲肾上腺素剂量>0.4 μg/kg/min)脓毒性休克患者中,单次治疗性血浆置换使组织因子6小时内相对变化为-18.3%(p<0.001),标准治疗组为+14%(p=0.089),组间p<0.001。
- 治疗性血浆置换使组织因子途径抑制剂6小时内相对变化为-20%(p<0.001),标准治疗组为+14.4%(p=0.076),组间p=0.022。
- 两组组织因子与组织因子途径抑制剂比值均未改变。
- 标准治疗组基线组织因子和组织因子途径抑制剂较高者24小时内乳酸升高;治疗性血浆置换组在所有基线水平下乳酸均持续下降。
- 多因素混合效应模型显示,基线组织因子(p=0.003)和基线组织因子途径抑制剂(p=0.053)越高,治疗性血浆置换组24小时内乳酸下降幅度越大。
适用人群与场景
- 早期(休克发生<24小时)且严重(去甲肾上腺素剂量>0.4 μg/kg/min)的脓毒性休克患者,共51例,其中标准治疗组14例、标准治疗+单次治疗性血浆置换组37例。
处置流程与药物剂量
- 标准治疗+单次治疗性血浆置换(37例)与标准治疗(14例)比较,在纳入研究时和纳入后6小时测量血浆组织因子和组织因子途径抑制剂浓度。
研究设计与关键结果
- 研究类型为汇总性事后生物样本库分析,纳入51例早期(休克发生<24小时)且严重(去甲肾上腺素剂量>0.4 μg/kg/min)的脓毒性休克患者,分为标准治疗组(n=14)和标准治疗+单次治疗性血浆置换组(n=37)。
- 组织因子6小时内相对变化:标准治疗组+14(-0.8至+30.4)%(p=0.089),治疗性血浆置换组-18.3(-32.6至-2.2)%(p<0.001),组间p<0.001。
- 组织因子途径抑制剂6小时内相对变化:标准治疗组+14.4(-2.3至+30.9)%(p=0.076),治疗性血浆置换组-20(-32.8至-7.9)%(p<0.001),组间p=0.022。
- 组织因子与组织因子途径抑制剂比值在标准治疗组和治疗性血浆置换组均未改变。
- 标准治疗组基线组织因子和组织因子途径抑制剂浓度较高者,24小时内乳酸升高;治疗性血浆置换组在所有基线组织因子和组织因子途径抑制剂升高水平下,乳酸浓度均持续纵向下降。
- 多因素混合效应模型显示,基线组织因子较高(p=0.003)和基线组织因子途径抑制剂较高(p=0.053)与治疗性血浆置换组24小时内乳酸浓度下降幅度更大相关。
证据类型、等级与局限
- 证据类型:汇总性事后生物样本库分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,脓毒性休克辅助治疗性血浆置换与组织因子和组织因子途径抑制剂显著清除相关,可能有助于接受治疗性血浆置换的脓毒性休克患者早期血流动力学改善。
- 作者认为,较高的基线组织因子(和组织因子途径抑制剂)血浆浓度是治疗反应的推定预测指标,可能有助于未来临床试验的预测富集策略。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Coagulopathy is part of the pathological host response to infection in sepsis. Higher plasma concentrations of both tissue factor (TF) and tissue factor pathway inhibitor (TFPI) are associated with occurrence of disseminated intravascular coagulation (DIC), multi-organ dysfunction and increased mortality in patients with sepsis. Currently no treatment approaches specifically targeting this axis are available. We hypothesize that therapeutic plasma exchange (TPE) might limit this coagulopathy by restoring the balance of plasma proteins.
METHODS: This was a pooled post-hoc biobank analysis including 51 patients with early (shock onset < 24 h) and severe (norepinephrine dose > 0.4 μg/kg/min) septic shock, who were either receiving standard of care treatment (SOC, n = 14) or SOC + one single TPE (n = 37). Plasma concentrations of TF and TFPI were measured both at- and 6 h after study inclusion. The effect of TPE on concentrations of TF and TFPI was investigated and compared to SOC patients. Further, baseline TF and TFPI concentrations were used to modulate and predict clinical response to adjunctive TPE, indicated by longitudinal reduction of lactate concentrations over the first 24 h following study inclusion.
RESULTS: TPE led to a significant reduction in circulating concentrations of both TF and TFPI while no difference was observed in the SOC group. Relative change of TF within 6 h was + 14 (-0.8 to + 30.4) % (p = 0.089) in the SOC and -18.3 (-32.6 to -2.2) % (p < 0.001) in the TPE group (between group p < 0.001). Similarly, relative change of TFPI was + 14.4 (-2.3 to + 30.9) % (p = 0.076) in the SOC and -20 (-32.8 to -7.9) % (p < 0.001) in the TPE group (between group p = 0.022). The ratio of TF to TFPI remained unchanged in both SOC and TPE groups. SOC patients exhibited an increase in lactate over the initial 24 h when TF and TFPI concentrations were higher at baseline. In contrast, patients undergoing TPE experienced a sustained longitudinal reduction of lactate concentrations across all levels of baseline TF and TFPI elevations. In a multivariate mixed-effects model, higher baseline TF (p = 0.003) and TFPI (p = 0.053) levels led to greater longitudinal lactate concentration reduction effects in the TPE group.
CONCLUSIONS: Adjunctive TPE in septic shock is associated with a significant removal of both TF and TFPI, which may contribute to the early hemodynamic improvement observed in septic shock patients receiving TPE. Higher baseline TF (and TFPI) plasma concentrations were identified as a putative predictor of treatment response that could be useful for predictive enrichment strategies in future clinical trials.
参考来源
- Stahl K, Lehner GF, Wendel-Garcia PD, et al. Effect of therapeutic plasma exchange on tissue factor and tissue factor pathway inhibitor in septic shock. Crit Care. 2024. PMID: 39478586. doi:10.1186/s13054-024-05142-4
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。